Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.94 $3.83 Thursday, 9th May 2024 CLRB stock ended at $3.24. This is 1.25% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.36% from a day low at $3.18 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Oct 20, 2016 $2.12 $2.15 $2.07 $2.09 48 700
Oct 19, 2016 $2.15 $2.25 $2.05 $2.13 69 000
Oct 18, 2016 $2.16 $2.22 $2.10 $2.14 68 200
Oct 17, 2016 $2.23 $2.36 $2.10 $2.10 140 800
Oct 14, 2016 $2.35 $2.49 $2.23 $2.23 102 000
Oct 13, 2016 $2.39 $2.50 $2.35 $2.39 62 300
Oct 12, 2016 $2.80 $2.80 $2.35 $2.39 113 800
Oct 11, 2016 $2.57 $2.62 $2.50 $2.52 101 000
Oct 10, 2016 $2.67 $2.68 $2.52 $2.59 67 300
Oct 07, 2016 $2.56 $2.75 $2.55 $2.67 68 500
Oct 06, 2016 $2.54 $2.61 $2.51 $2.61 99 900
Oct 05, 2016 $2.67 $2.73 $2.41 $2.62 186 400
Oct 04, 2016 $2.89 $2.91 $2.62 $2.70 187 100
Oct 03, 2016 $2.68 $2.80 $2.67 $2.73 109 200
Sep 30, 2016 $2.62 $2.82 $2.62 $2.71 180 000
Sep 29, 2016 $3.12 $3.19 $2.61 $2.71 730 000
Sep 28, 2016 $2.72 $2.85 $2.69 $2.76 125 400
Sep 27, 2016 $2.66 $2.79 $2.63 $2.71 90 500
Sep 26, 2016 $2.85 $2.85 $2.63 $2.66 130 100
Sep 23, 2016 $2.79 $2.84 $2.73 $2.74 69 300
Sep 22, 2016 $2.85 $2.85 $2.78 $2.78 72 700
Sep 21, 2016 $2.77 $2.84 $2.73 $2.76 151 300
Sep 20, 2016 $2.79 $2.81 $2.67 $2.72 74 600
Sep 19, 2016 $2.84 $2.93 $2.75 $2.82 95 000
Sep 16, 2016 $2.67 $2.95 $2.66 $2.87 247 400
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT